Daniel Eckert

Daniel Eckert is an accomplished professional in the field of biotechnology and pharmaceutical sciences, currently serving as Associate Director of CMC Management RNA at BioNTech SE since February 2022. Prior experience includes roles such as CMC Project Manager at Heidelberg Immunotherapeutics, where responsibilities encompassed CMO correspondence, stability studies, and product specifications. Earlier positions involved research roles focusing on preclinical R&D and antibody production at various institutions, including the National Center for Tumor Diseases and Horizon Discovery, utilizing advanced techniques such as CRISPR/Cas9. Daniel Eckert holds a Master of Science in Molecular Biotechnology from the University of Applied Sciences - FH Campus Wien and a Bachelor of Science in Biochemistry from Technische Hochschule Mannheim.